Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
rare diseases
Biotech
Applied lays off 46% of workforce as rare disease plans stall
Applied Therapeutics is laying off almost half its workforce to conserve its remaining cash.
James Waldron
Nov 20, 2025 9:10am
Analysts skeptical Applied can bring rare disease drug to market
Nov 14, 2025 5:25am
Lilly bags eye-catching gene therapy in $475M deal
Nov 10, 2025 7:00am
FDA rejects Biohaven approval request, triggering cost cutting
Nov 5, 2025 4:02am
Sanofi's $1.7B bet beats CSL's Zemaira in phase 2 face-off
Oct 22, 2025 10:35am
Electra shines with $183M fundraise for rare disease trial
Oct 22, 2025 8:26am